Cancer is a leading cause of morbidity and mortality worldwide. Over the past decades, the
concept of precision cancer medicine has emerged as a novel approach in the field of …

Oncologists should recognise the need to move beyond the Eastern Cooperative Oncology
Group Performance Status (ECOG PS) score. ECOG PS is a longstanding and ubiquitous …

Lung cancer is the leading cause of cancer-related deaths worldwide and in China.
Screening for lung cancer by low dose computed tomography (LDCT) can reduce mortality …

E-cadherin (CDH1 gene) germline mutations are associated with the development of diffuse
gastric cancer in the context of the so-called hereditary diffuse gastric syndrome, and with an …

Stage III N2 nonsmall cell lung cancer (NSCLC) is a complex disease with poor treatment
outcomes. For patients in whom the disease is considered technically resectable, the main …

Abstract Objectives Patient-reported outcomes (PROs) describe a patient's unique
experiences with disease or treatment, yet effective use of this information during clinical …

Emotions play an important role in decision-making and they can impact individual as well
as shared decisions. With increasing complexity of the decision, the potential for emotions to …

Background Shared decision making (SDM) is recognized as the gold standard for patient-
centered care. This study aimed to assess and compare the SDM among patients …

As the aging population grows, so too does the number of well-tolerated antimyeloma
therapies. Physicians will see an increasing volume of patients for subsequent lines of …

Chimeric antigen receptor T-cell (CAR-T) therapy is a paradigm-shifting immunotherapy
modality in oncology; however, unique toxicities such as cytokine release syndrome (CRS) …